In life sciences, breakthroughs are reshaping healthcare faster than ever. But true leadership means going beyond the lab – understanding the complex ecosystem where science, policy, and business collide. For those struggling to navigate this complexity, WU Vienna’s Executive MBA offers the insights and connections needed to stay ahead in an unpredictable industry.
Bayer Berlin develops a life sciences campus
BackgroundIt all began with a view from the window of the 15th floor of Bayer’s site in Berlin, reminiscent of Boston before it became one of the most important biotech hotspots in the world. This inspired the vision of developing the Bayer Campus into “Boston an der Spree” – a vibrant healthcare campus that fosters collaboration and innovation.
Argenx and Unnatural Products ink US$1.5bn macrocycle deal
Latest NewsCalifornia oral macrocyclic peptide specialist Unnatural Products, Inc. and Dutch-Belgian Argenx SE have formed a multi-target research collaboration aimed at developing oral macrocyclic peptide drugs with UNP’s synthetic macrocycle platform.
Vetter invests US$285m in Chicago production facility
Latest NewsCDMO and filled syringe specialist Vetter has broken the ground for a new clinical site construction in the greater Chicago area that is expected to be ready for early clinical filling by the end of 2029.
Altri acquires majority stake in fibre specialist AeoniQ
Latest NewsPortuguese fibre producer Altri SGPS S.A.has signed an agreement to acquire a majority interest in Swiss clean technology company AeoniQ to support the commercial-scale development of the first fully biodegradable cellulose-based filament designed to replace polyester and nylon.
Why life sciences leaders need more than science
BackgroundIn life sciences, breakthroughs are reshaping healthcare faster than ever. But true leadership means going beyond the lab – understanding the complex ecosystem where science, policy, and business collide. For those struggling to navigate this complexity, WU Vienna’s Executive MBA offers the insights and connections needed to stay ahead in an unpredictable industry.
Accelerating Europe’s Biotech Revolution
OpinionAs the global race for biosolutions intensifies, Europe is at a critical crossroads, and I am deeply concerned about the future of our continent’s biotech industry. While countries like China and the United States rapidly advance their biotech industries, Europe’s slow and not up-to-date regulatory system poses a significant risk to maintaining our leadership.
Parliament halts trilogue talks on New Genomic Breeding Techniques
Latest NewsFinal negotiations on proposed EU regulations for plants developed through genetic precision breeding have been delayed, following opposition from a group of MEPs in the European Parliament’s ENVI Committee. The group criticised the European Council and the European Commission for their inflexible stance on issues such as sustainability, labelling, and patent protection.
Laverock Therapeutics bags additional £6.5m seed money
Latest NewsBritish targeted gene silencing specialist Laverock Therapeutics Ltd has expanded its seed funding to £20m by a new financing round led by xx and xx. The company said it will use the funds to…l
Unlocking the Future of Precision Biology with Spatial Cell Sorting
slider, Sponsored PublicationsSpatial precision in cell analysis is revolutionizing biomedical research. SLACS (Spatially-resolved Laser Activated Cell Sorting) uniquely isolates live microniches within tissues, preserving spatial context and enabling deep biological insights.
EU Commissioner Várhelyi revives Biotech Act for 2025
Latest NewsIn a surprise move, Health Commissioner Oliver Várhelyi announced at the Medicines for Europe Annual Conference that the EU Biotech Act will go ahead this year, reversing its provious delay from Q3 2025 to Q3 2026. The legislation has now been fast-tracked because the Commission recognised biotechnology’s rising geostrategic weight.